Pregabalin and Toxic skin eruption - a phase IV clinical study of FDA data

Summary:

Toxic skin eruption is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Endometrial cancer.

The phase IV clinical study analyzes which people have Toxic skin eruption when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Toxic skin eruption?

Toxic skin eruption (skin breakdown due to toxic substance) is found to be associated with 638 drugs and 1,064 conditions by eHealthMe. Check the latest studies of Toxic skin eruption.

On Jul, 16, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 30 people (0.04%) have Toxic skin eruption.

Could Pregabalin cause Toxic skin eruption?

Among these 30 people:

How long have people been on Pregabalin when they have Toxic skin eruption? *

What is the gender of people who have Toxic skin eruption when taking Pregabalin? *

female: 76.67 %
male: 23.33 %

What is the age of people who have Toxic skin eruption when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

What are other side effects people have besides Toxic skin eruption? *

Sputum Discolored: 4 people, 13.33%
Cough: 4 people, 13.33%
Itching: 4 people, 13.33%
Fatigue (feeling of tiredness): 4 people, 13.33%
Viral Rash: 4 people, 13.33%
Rashes (redness): 3 people, 10.00%
Rash Papular (redness with papule): 3 people, 10.00%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 3 people, 10.00%
White Blood Cell Count Decreased: 2 people, 6.67%
Gardnerella Test Positive: 2 people, 6.67%

What are the existing conditions these people have? *

Endometrial Cancer: 5 people, 16.67%
Dermo-Hypodermitis (skin and subcutaneous tissue bacterial infections): 4 people, 13.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 6.67%
Erythromelalgia (episodes of pain, redness, and swelling in various parts of the body): 2 people, 6.67%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 3.33%
Headache (pain in head): 1 person, 3.33%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 3.33%
Dupuytren's Contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers): 1 person, 3.33%
Fungal Skin Infection: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Toxic skin eruption?

- Check whether Toxic skin eruption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,069 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toxic skin eruption:

Toxic skin eruption (638 drugs)

Browse all the conditions that are associated with Toxic skin eruption:

Toxic skin eruption (1,064 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.